The clinical and public health importance of influenza and other respiratory 2 viruses has accelerated the development of highly sensitive molecular diagnostics, but 3 data are limited regarding pre-analytical stages of diagnostic testing. We evaluated 4
in CyMol transport media, as a measure of biosafety; and 3) the compatibility of CyMol 1 with antigen or nucleic-acid based diagnostic tests for respiratory tract viruses. temperate, cooler or tropical conditions. The collection tubes with swabs were held at 16 each temperature for 1, 7, 14 or 21 days before nucleic acid extraction. To release the 17 virus from the swab, the CyMol and UTM-RT mock samples were briefly vortexed and 18 the swab was then discarded. For the dry swab collection, one mL of UTM-RT was 19 added after mock storage, the swab vortexed and discarded. 20
To recover viral RNA, a 500 uL aliquot of the mocked specimens was extracted 21 by easyMAG (bioMérieux, Montreal QC) and eluted in 60 uL. The type of collection systems had less effect than temperature or duration of 22 storage. Both CyMol and UTM-RT collection systems were essentially identical, and 23 superior to dry swab collection. Equivalent viral quantification (within 0.5 log copies 1 from baseline) was found in CyMol and UTM-RT at -20 0 C, 4 0 C and RT up to 14 days. 2
At 21 days, CyMol-collected swabs had a greater viral copy number than UTM-RT-3 collected swabs (4.63 versus 4.08 log copies), but there was no overall difference 4 between CyMol and UTM-RT in a statistical model adjusted for temperature and days of 5 storage (mean difference 0.21 log copies, P=0.13). In contrast, dry swabs were associated 6 with lower viral quantities at RT and 37 0 C at all time points beyond 1 day. However, 7 dry swab collection yielded stable quantification at 4 0 C and at -20 0 C for up to 21 days. 8
To assess the inactivation of influenza virus in CyMol transport medium, mocked 9 specimens stored for various times at RT were tested. After RT exposure to the CyMol 10 In this study, these pre-analytical issues were addressed with three sample 22 collection systems that have potential utility in an influenza pandemic. We assessedmocked and clinical nasal flocked swab specimens placed into CyMol or UTM-RT 1 media, or kept as a dry swab. We found that CyMol-an alcohol-based transport 2 medium-enabled reliable quantitation of virus for at least 14 days at room temperature, 3 rapidly inactivated influenza viruses, and was equivalent to UTM-RT for multiplex PCR 4 detection of influenza and other respiratory viruses in flocked nasal mid-turbinate swabs. temperatures, which may greatly facilitate transportation for clinical, public health, and 21 research purposes. This may be particularly important for collection of specimens in sitesremote from the referral laboratory, including isolated communities. Viral nucleic acid 1 quantities deteriorated more rapidly at higher temperatures. 2 UTM-RT is widely used as a viral transport medium, but little has been published 3 regarding the stability of respiratory viruses at various temperatures and storage times. 4
We found that samples in UTM-RT were stable at room temperature for up to 14 days, 5 and for at least 21 days if refrigerated or frozen. Additionally, UTM-RT has been 6 reported as superior to other transport media for room temperature storage and shipping 7 in terms of preservation of viability (7, 16). RT by NASBA (13). Our methods for quantification by PCR may be more precise, and 3 our findings indicate a relative, not an absolute, decrease in viral quantification after 1 4
day. An alcohol-based collection medium such as CyMol has the added advantage that it 5 rapidly renders specimens non-infectious, reducing the risk to couriers and laboratory 6 staff from sample leakage or laboratory manipulation. Virus inactivation at source may 7 reduce packaging and transportation costs if a lower biohazard level could be assigned to 8 such diagnostic specimens in future. Consequently, CyMol is a potential alternative for 9 safe sample collection and transportation during influenza or other respiratory virus 10 pandemics. 11
A variety of solvents and detergents have been investigated for their ability to 12 inactivate viral infectivity (4, 14). Alcohol is widely used as a disinfectant to inactivate 13 viruses and bacteria, and its effectiveness on enveloped viruses has been well 14 documented (8, 9, 15). Inactivation of infectivity also occurs with the RNA stabilizing 15 agent AVL, although RNAlater™ maintains infectivity (1, 2). We showed that CyMol 16 rapidly inactivated various influenza viruses without affecting PCR detection and 17
quantification. 18
Our clinical evaluation involved a blinded, randomized comparison of CyMol 19 versus UTM-RT. Both transport systems proved equivalent for PCR testing giving 20 similar yields. Our study also provides further validation for self-collection of nasal mid-21 turbinate flocked swabs as equivalent to staff-collected nasal swabs. 22 DFA testing was clearly inferior to PCR testing. PCR had a higher tolerance for 1 specimen inadequacy than DFA. In addition, with multiplex PCR testing, we were able to 2 detect coronaviruses and rhino/enteroviruses for which DFA testing is not available. 3
Furthermore, and contrary to our expectations, UTM-RT-based media were more 4 sensitive than CyMol-based media for DFA. A greater number of swabs in CyMol had 5 non-sufficient cell quantity, despite randomization to ensure an equal distribution of first 6 and second-collected swabs. Lower cell counts, coupled with lower beta-actin 7 quantitation, suggest that fewer cells were released from the swab. Lower cell counts 8 could also be due to a lack of protein in CyMol, which may affect adherence to the glass 9 slides. In contradistinction, experience with CyMol for cytologic studies did not find any 10 degradation of cells (Castriciano 2009, unpublished) . Further work is needed to optimize 11 alcohol-based transport media for antigen detection. For clinical diagnosis or for 12 epidemiologic research, the use of self-collected nasal swabs needs to be coupled with 13 highly-sensitive multiplex PCR to achieve high diagnostic yield. 14 We acknowledge a number of limitations to our study. Virus stability and 15 infectivity were mocked, and may not represent the full range of diagnostic situations in 16 which virus collection may take place. For the clinical validation, there were insufficient 17 positive samples for a number of respiratory viruses limiting our ability to draw specific 18 conclusions on the stability of each individual virus in CyMol. We used one extraction 19 method (easyMAG), and cannot generalize our findings to all extraction systems. 20 Importantly, while CyMol will enable safer collection and transportation of specimens, 21 the inability to culture inactivated virus may be a limitation for reference laboratories 22 charged with such requirements for antigenic characterization or for phenotypic drug 23 resistance testing. The majority of routine respiratory testing is currently done either by 1 antigen detection, or by molecular methods, and the need for routine culture is likely to 2 be greatly reduced in future. 3 We conclude that the alcohol-based transport medium, CyMol, a Quantitative RT-PCR targeting the influenza A matrix gene was used to assess viral 4 genomic copy number in duplicate, and expressed as log 10 genome equivalents. 
